Depending upon your perspective, “emerging” biotech could mean any number of things, ranging all the way from the recent spinout of an academic lab to a publicly held company developing a therapeutic that has not yet reached the marketplace. My company, Respana Therapeutics (a finalist in North America Advance Biotech Grant Program) sits at the … Continue reading Mind the Gaps: A Perspective from the World of Academic Spinouts